Emmaus Life Sciences (EMMA) Short Interest Ratio & Short Volume

Short interest is the volume of Emmaus Life Sciences shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 700 shares of EMMA short. Learn More on Emmaus Life Sciences' current short interest.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Emmaus Life Sciences: Shuttle Pharmaceuticals Holdings, Inc. (0.74%), TransCode Therapeutics, Inc. (2.29%), Processa Pharmaceuticals, Inc. (24.82%), Tenax Therapeutics, Inc. (1.20%), Pulmatrix, Inc. (0.08%), Theriva Biologics, Inc. (2.95%), ASLAN Pharmaceuticals Limited (4.12%), Ainos, Inc. (2.12%), Pasithea Therapeutics Corp. (1.34%), CannaPharmaRX, Inc. (0.00%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

Short selling EMMA is an investing strategy that aims to generate trading profit from Emmaus Life Sciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Emmaus Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EMMA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EMMA, twice per month. The most recent reporting period available is April, 30 2024.